Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Ratings

Analyst Ratings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Argus Research Maintains Buy on FedEx, Raises Price Target to $240

By Benzinga Newsdesk
Today, 12:25 PM
Argus Research analyst John Eade maintains FedEx (NYSE:FDX) with a Buy and raises the price target from $200 to $240.

FDX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

JMP Securities Reiterates Market Outperform on W.P. Carey, Maintains $86 Price Target

By Benzinga Newsdesk
Today, 12:25 PM
JMP Securities analyst Mitchell Germain reiterates W.P. Carey (NYSE:WPC) with a Market Outperform and maintains $86 price target.

WPC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Stephens & Co. Reiterates Overweight on Akoya Biosciences, Maintains $16 Price Target

By Benzinga Newsdesk
Today, 12:25 PM
Stephens & Co. analyst Mason Carrico reiterates Akoya Biosciences (NASDAQ:AKYA) with a Overweight and maintains $16 price target.

AKYA

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Wells Fargo Maintains Underweight on Molina Healthcare, Lowers Price Target to $282

By Benzinga Newsdesk
Today, 12:25 PM
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $307 to $282.

MOH

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Needham Maintains Buy on Stagwell, Lowers Price Target to $8

By Benzinga Newsdesk
Today, 12:25 PM
Needham analyst Laura Martin maintains Stagwell (NASDAQ:STGW) with a Buy and lowers the price target from $9 to $8.

STGW

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Long Ideas
  • News
  • Reiteration
  • Tech
  • Trading Ideas

Tesla Price Cuts May Have Hurt Its Margin, Says Analyst: Why Investors Shouldn’t Worry About It

By Shanthi Rexaline
Today, 12:25 PM
Morgan Stanley, which recently dropped Tesla Inc. (NASDAQ: TSLA) as its top U.S.

TSLA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Price Target
  • Reiteration

Darden Restaurants Has Strong Brand Value And Benefits Of Scale, Says Analyst

By Shivani Kumaresan
Today, 12:25 PM
Raymond James analyst Brian M.Vaccaro reiterated an Outperform rating on the shares of Darden Restaurants Inc (NYSE:DRI) with a price target of…

DRI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Deutsche Bank Maintains Buy on Colgate-Palmolive, Lowers Price Target to $80

By Benzinga Newsdesk
Today, 12:25 PM
Deutsche Bank analyst Steve Powers maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $84 to $80.

CL

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Fermium Research Downgrades Univar Solns to Hold, Raises Price Target to $36.15

By Benzinga Newsdesk
Today, 12:25 PM
Fermium Research analyst Frank Mitsch downgrades Univar Solns (NYSE:UNVR) from Buy to Hold and raises the price target from $35 to $36.15.

UNVR

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Rosenblatt Reiterates Buy on Seagate Tech Hldgs, Maintains $75 Price Target

By Benzinga Newsdesk
Today, 12:25 PM
Rosenblatt analyst Kevin Cassidy reiterates Seagate Tech Hldgs (NASDAQ:STX) with a Buy and maintains $75 price target.

STX

Posts navigation

Previous 1 2 3 4 … 5,655 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service